Correlation Between Tscan Therapeutics and Abcellera Biologics
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and Abcellera Biologics, you can compare the effects of market volatilities on Tscan Therapeutics and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Abcellera Biologics.
Diversification Opportunities for Tscan Therapeutics and Abcellera Biologics
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Tscan and Abcellera is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Abcellera Biologics go up and down completely randomly.
Pair Corralation between Tscan Therapeutics and Abcellera Biologics
Given the investment horizon of 90 days Tscan Therapeutics is expected to under-perform the Abcellera Biologics. In addition to that, Tscan Therapeutics is 1.36 times more volatile than Abcellera Biologics. It trades about -0.16 of its total potential returns per unit of risk. Abcellera Biologics is currently generating about 0.06 per unit of volatility. If you would invest 275.00 in Abcellera Biologics on September 13, 2024 and sell it today you would earn a total of 27.00 from holding Abcellera Biologics or generate 9.82% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Tscan Therapeutics vs. Abcellera Biologics
Performance |
Timeline |
Tscan Therapeutics |
Abcellera Biologics |
Tscan Therapeutics and Abcellera Biologics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tscan Therapeutics and Abcellera Biologics
The main advantage of trading using opposite Tscan Therapeutics and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.Tscan Therapeutics vs. Puma Biotechnology | Tscan Therapeutics vs. Iovance Biotherapeutics | Tscan Therapeutics vs. Sarepta Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals |
Abcellera Biologics vs. Hepion Pharmaceuticals | Abcellera Biologics vs. Krystal Biotech | Abcellera Biologics vs. CureVac NV | Abcellera Biologics vs. Vir Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Money Managers Screen money managers from public funds and ETFs managed around the world |